This article covers Rabeprazole Sodium, available as a generic medication and marketed under brand names such as Aciphex, Pariet, and others.
Rabeprazole Sodium belongs to the Digestive Health therapeutic class as a proton-pump inhibitor (PPI). It is supplied as a pill in strengths of 10 mg and 20 mg. In Hong Kong, rabeprazole is a prescription-only medicine regulated by the Hong Kong Department of Health.
These indications are approved by regulatory agencies such as the U.S. FDA and are recognized by the Hong Kong Department of Health for clinical practice.
Evidence-Based Off-Label Uses
Regulatory Status & Disclaimer
Absolute contraindications
Known hypersensitivity to rabeprazole sodium or any other PPI.
Co-administration with drugs that require an acidic gastric environment for absorption (e.g., ketoconazole, atazanavir) unless alternative dosing strategies are employed.
Relative contraindications / cautions
Severe hepatic impairment (dose adjustment may be needed).
Pregnancy and lactation: limited human data; use only if the potential benefit justifies the potential risk.
Elderly patients: higher risk of fractures and Clostridioides difficile infection; monitor closely.
Special populations
Pregnancy: Category C (animal studies show risk; no adequate human studies).
Breast-feeding: Small amounts appear in milk; benefits and risks should be weighed.
Renal impairment: No dose adjustment required for mild to moderate dysfunction, but monitor for accumulation in severe cases.
These effects are generally mild and transient, often resolving without intervention.
If any of these serious events occur, seek medical attention promptly.
Interaction mechanisms often involve CYP2C19 inhibition or changes in gastric pH.
Standard dosing (based on available strengths)
GERD, erosive oesophagitis, ulcer healing: 20 mg once daily, usually taken before the first meal of the day.
H. pylori eradication regimens: 10 mg to 20 mg twice daily, combined with antibiotics as prescribed.
NSA-ID ulcer prevention: 20 mg once daily, taken at least 30 minutes before the NSA-ID.
Special populations
Elderly: start at the lowest effective dose; monitor for fractures or infections.
Severe hepatic impairment: consider a reduced dose (e.g., 10 mg once daily) and monitor liver function.
Administration details
Swallow the pill whole; do not crush or chew.
Store at room temperature, away from moisture and heat.
Missed dose
Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose. Do not double-dose.
Overdose
Symptoms may include nausea, vomiting, abdominal pain, and dizziness. Seek emergency care; no specific antidote is required.
Discontinuation
Long-term users should discuss tapering with their provider to avoid rebound hyperacidity.
This article provides educational information about rabeprazole sodium and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, but separate the doses by at least 2 hours. Antacids may neutralise the stomach acidity needed for rabeprazole to act on the proton pump.
Rabeprazole has no direct effect on common antihypertensives, but it can alter the absorption of drugs that require an acidic environment, such as some calcium channel blockers. Discuss any concerns with your pharmacist.
Take the missed dose as soon as you remember, provided it is not within 12 hours of the next scheduled dose. Otherwise, skip the missed dose and resume your regular schedule.
In most manufacturers, the 10 mg tablet is smaller and lighter than the 20 mg tablet, but imprint codes and color can vary by brand. Always verify the imprint before use.
Yes, PPIs, including rabeprazole, are often prescribed for stress ulcer prophylaxis in high-risk in-patients, though the decision rests with the treating physician.
Short-term use (<8 weeks) is unlikely to cause clinically significant deficiencies, but long-term therapy may impair absorption of vitamin B12, magnesium, and calcium.
Rabeprazole does not directly influence kidney stone formation. However, chronic use may increase calcium excretion; patients with a predisposition should be monitored.
No, rabeprazole does not interfere with bowel preparation. Continue the medication unless your gastroenterologist advises otherwise.
Rabeprazole is a prescription-only medicine in Hong Kong; purchasing it without a valid prescription is not legal and may pose safety risks.
Rabeprazole has a faster onset of action and is less dependent on CYP2C19 metabolism, which can lead to more consistent acid suppression in patients with genetic variations.
